Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis

• Status: Completed
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the dietary and therapeutic effect of supplement consisting of sublimated mare milk among patients with non-alcoholic steatohepatitis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical Centre Hospital of the President's Affairs Administration, Republic of Kazakhstan; Medical Centre Hospital of the President’s Affairs Administration, Republic of Kazakhstan
• Collaborators: Eurasia Invest Ltd.; Ministry of Education and Science, Republic of Kazakhstan
• Treatments: Ursodeoxycholic Acid

Criteria

Inclusion Criteria:

• Patients with a verified diagnosis of non-alcoholic steatohepatitis;

• Aged 16 to 60 years;

• Absence of an allergic reaction to dairy products;

• Willingness to consent to participate in the study.

• Consent to adhere to treatment

Exclusion Criteria:

• Taking antibiotics, cytostatics and steroids during the last 3 months;

• Taking alcohol hepatotoxic doses (no more than 30 g alcohol per day for men and not more than 20 g for women);

• History of oncological diseases;

• Presence of diabetes mellitus, decompensated forms of diseases, intestinal dyspepsia, hypertension (blood pressure 140/90 mm Hg and more at the time of the initial visit to the doctor), tuberculosis;

• A positive result of screening for antibodies to viral hepatitis B, C and D, as well as HIV

• Presence of concomitant diseases of the kidneys, liver, cardiovascular, respiratory and other body systems, oncological, mental health and decompensated endocrine diseases, tuberculosis, and HIV infection;

• Pregnancy and/or lactation;

• Patient involvement in other clinical trials within the last 3 months;

• Refusal to participate in the study.